Borosil Renewables (BORORENEW) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
18 Nov, 2025Executive summary
Standalone Q1 FY26 sales reached INR 332.26 crores, up 37% year-over-year, driven by higher selling prices and robust domestic demand.
EBITDA surged 211% year-over-year to INR 92.53 crores, with margins improving to 27.8% due to price increases and anti-dumping duties.
A one-time provision of INR 325.91 crores was made for the German subsidiary's insolvency, removing future drag on consolidated results.
Strategic exit from European operations via insolvency of German subsidiary, with focus realigned to Indian market and capacity expansion.
Consolidated Q1 FY26 net loss was Rs. 20,348.68 lakhs, significantly impacted by exceptional items related to subsidiary insolvency.
Financial highlights
Standalone sales: INR 332.26 crores (Q1 FY26) vs INR 241.82 crores (Q1 FY25); Q1 FY26 revenue up 37.4% year-over-year.
EBITDA: INR 92.53 crores (27.8% margin), up from INR 29.71 crores (Q1 FY25); exceptional item: INR 325.91 crores provision for German subsidiary.
Exports: INR 35.67 crores, 10.7% of turnover, up from 5.8% in the previous quarter.
Basic and diluted EPS (after exceptional items) for the quarter were Rs. (12.56) consolidated and Rs. (20.54) standalone.
Consolidated total expenses for Q1 FY26 were Rs. 31,727.96 lakhs, down from Rs. 40,386.97 lakhs in the previous quarter.
Outlook and guidance
Expectation of further improvement in sales and EBITDA for FY26, supported by strong domestic demand and stable prices.
EBITDA margin guidance of 28-30% for the coming quarters, with potential for a couple of percentage points improvement.
Volume growth of 6-8% expected for FY26; capacity utilization at 95%.
New 600 TPD capacity to be fully stabilized by March 2027; expansion plan to be commissioned by Dec 2026.
No explicit forward-looking guidance for the German subsidiary due to ongoing insolvency proceedings.
Latest events from Borosil Renewables
- Q1 FY27 saw strong revenue and EBITDA growth, with capacity expansion and funding progressing.BORORENEW
Q1 26/2720 Jul 2026 - Strong Indian margin recovery and expansion plans offset export and European losses.BORORENEW
Q4 24/259 Jul 2026 - Sequential margin gains and revenue growth, but losses persist amid export and cost pressures.BORORENEW
Q1 24/259 Jul 2026 - Margins fell despite revenue growth; expansion and capital raise aim to support recovery.BORORENEW
Q3 24/258 Jul 2026 - Strong Q2 growth and margins, but European losses offset gains; expansion and capital raise ongoing.BORORENEW
Q2 25/2619 Jun 2026 - Record revenue, robust margins, and expansion plans drive strong growth despite European write-offs.BORORENEW
Q4 25/2613 May 2026 - Record sales, strong margins, and expansion plans offset by European subsidiary insolvencies.BORORENEW
Q3 25/263 Feb 2026 - Q2 margins and profit improved, but overseas losses and regulatory delays affect expansion.BORORENEW
Q2 24/2515 Jan 2026